These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17308019)

  • 1. Efficacy of an inactivated aqueous vaccine for the control of enzootic pneumonia in pigs infected with Mycoplasma hyopneumoniae.
    Tzivara A; Kritas SK; Bourriel AR; Alexopoulos C; Kyriakis SC
    Vet Rec; 2007 Feb; 160(7):225-9. PubMed ID: 17308019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.
    Wilson S; Van Brussel L; Saunders G; Taylor L; Zimmermann L; Heinritzi K; Ritzmann M; Banholzer E; Eddicks M
    Vaccine; 2012 Dec; 30(52):7625-9. PubMed ID: 23084853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of intradermal vaccination against porcine enzootic pneumonia (Mycoplasma hyopneumoniae).
    Tassis PD; Papatsiros VG; Nell T; Maes D; Alexopoulos C; Kyriakis SC; Tzika ED
    Vet Rec; 2012 Mar; 170(10):261. PubMed ID: 22262700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field study on the safety and efficacy of intradermal versus intramuscular vaccination against
    Beffort L; Weiß C; Fiebig K; Jolie R; Ritzmann M; Eddicks M
    Vet Rec; 2017 Sep; 181(13):348. PubMed ID: 28893974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
    Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
    Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
    Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
    Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
    Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G
    Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
    Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
    BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
    Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
    Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
    Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
    Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs.
    Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX
    Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
    Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
    Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
    Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
    Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
    Moreau IA; Miller GY; Bahnson PB
    Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity of Mycoplasma hyopneumoniae isolates from conventional farrow-to-finish pig farms in Serbia.
    Savic B; Ivetic V; Milicevic V; Pavlovic I; Zutic M; Gagrcin M
    Acta Vet Hung; 2010 Sep; 58(3):297-308. PubMed ID: 20713321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
    Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
    BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination reduces macrophage infiltration in bronchus-associated lymphoid tissue in pigs infected with a highly virulent Mycoplasma hyopneumoniae strain.
    Vranckx K; Maes D; Marchioro SB; Villarreal I; Chiers K; Pasmans F; Haesebrouck F
    BMC Vet Res; 2012 Mar; 8():24. PubMed ID: 22409839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
    Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
    BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.